FAOSX
Price
$33.88
Change
-$0.17 (-0.50%)
Updated
Nov 6 closing price
RERFX
Price
$58.29
Change
-$0.48 (-0.82%)
Updated
Nov 6 closing price
Ad is loading...

FAOSX vs RERFX

Header iconFAOSX vs RERFX Comparison
Open Charts FAOSX vs RERFXBanner chart's image
Fidelity Advisor Overseas Z
Price$33.88
Change-$0.17 (-0.50%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R5
Price$58.29
Change-$0.48 (-0.82%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FAOSX vs RERFX Comparison Chart
Loading...
VS
FAOSX vs. RERFX commentary
Nov 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAOSX is a Sell and RERFX is a Buy.

FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 135B vs. FAOSX (384M). RERFX pays higher dividends than FAOSX: RERFX (1.79) vs FAOSX (1.04). FAOSX was incepted earlier than RERFX: FAOSX (8 years) vs RERFX (23 years). FAOSX is a more actively managed with annual turnover of: 37.00 vs. RERFX (34.00). FAOSX has a lower initial minimum investment than RERFX: FAOSX (0) vs RERFX (250). FAOSX annual gain was more profitable for investors over the last year : 22.92 vs. RERFX (15.18). FAOSX return over 5 years is better than : 38.52 vs. RERFX (11.50).
FAOSXRERFXFAOSX / RERFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD8.9047.148125%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets384M135B0%
Annual Yield % from dividends1.041.7958%
Returns for 1 year22.9215.18151%
Returns for 3 years-3.43-14.6124%
Returns for 5 years38.5211.50335%
Returns for 10 yearsN/A28.49-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCML27.532.44
+9.72%
BayCom Corp
TS36.532.79
+8.27%
Tenaris S A
CVI17.340.95
+5.80%
CVR Energy
BBDC9.780.28
+2.95%
Barings BDC
PIRS16.70-0.29
-1.74%
Pieris Pharmaceuticals